Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer

Abstract

AIM: To investigate feasibility, morbidity and surgical mortality of a docetaxel-based chemotherapy regimen randomly administered before or after gastrectomy in patients suffering from locally-advanced resectable gastric cancer